STOMP: Small Cell Lung Cancer Trial of Olaparib (AZD2281) as Maintenance Programme: a randomised, double blind, multicentre phase II trial

Project Details

Short titleSTOMP: Small Cell Lung Cancer Trial of Olaparib (AZD2281) as Maintenance Programme: a randomised, double blind, multicentre phase II trial
StatusActive
Effective start/end date1/07/1131/12/23

Funding

  • ASTRA ZENECA UK LIMITED